292 results on '"Brennand, JE"'
Search Results
2. FIRST TRIMESTER E-SELECTIN LEVELS PREDICT PRE-ECLAMPSIA: PP.12.468
- Author
-
Carty, DM, primary, Brennand, JE, additional, Mcculloch, JW, additional, Johnstone, J, additional, Welsh, P, additional, Delles, C, additional, and Dominiczak, AF, additional
- Published
- 2010
- Full Text
- View/download PDF
3. PERIPHERAL ARTERIAL TONE TECHNOLOGY TO ASSESS ENDOTHELIAL FUNCTION IN PREGNANCY: PP.3.128
- Author
-
Carty, DM, primary, Brennand, JE, additional, Delles, C, additional, and Dominiczak, AF, additional
- Published
- 2010
- Full Text
- View/download PDF
4. INTERPLAY OF PRO- AND ANTI-INFLAMMATORY MOLECULES IN NORMAL PREGNANCY AND POST-PARTUM: 2C.07
- Author
-
Carty, DM, primary, Brennand, JE, additional, McCulloch, JW, additional, Welsh, P, additional, Delles, C, additional, and Dominiczak, AF, additional
- Published
- 2010
- Full Text
- View/download PDF
5. Current methods of screening for Down syndrome
- Author
-
Brennand, JE, primary and Cameron, AD, additional
- Published
- 2001
- Full Text
- View/download PDF
6. Human parvovirus B19 in pregnancy
- Author
-
Brennand, JE, primary and Cameron, AD, additional
- Published
- 2000
- Full Text
- View/download PDF
7. Fetal Heart — Abnormal Appearances
- Author
-
Brennand, JE, primary and Macara, LM, additional
- Published
- 1999
- Full Text
- View/download PDF
8. Clinical Evaluation of Cervical Ripening in the Outpatient Setting
- Author
-
Maria de Carvalho Afonso, Medical Doctor, Phd Student
- Published
- 2024
9. Obstetric and long-term kidney outcomes in renal transplant recipients: a 40-yr single-center study.
- Author
-
Stoumpos S, McNeill SH, Gorrie M, Mark PB, Brennand JE, Geddes CC, and Deighan CJ
- Subjects
- Adult, Case-Control Studies, Female, Graft Survival, Humans, Incidence, Infant, Newborn, Pregnancy, Retrospective Studies, Transplant Recipients, United Kingdom epidemiology, Delivery, Obstetric statistics & numerical data, Kidney physiopathology, Kidney Transplantation, Pregnancy Complications epidemiology, Pregnancy Outcome
- Abstract
Female renal transplant recipients of childbearing age may ask what the outcomes are for pregnancy and whether pregnancy will affect graft function. We analyzed obstetric and transplant outcomes among renal transplant recipients in our center who have been pregnant between 1973 and 2013. A case-cohort study was performed identifying 83 pairs of pregnant and non-pregnant controls matched for sex, age, transplant vintage, and creatinine. There were 138 pregnancies reported from 89 renal transplant recipients. There were live births in 74% of pregnancies with high prevalence of prematurity (61%), low birth weight (52%), and pre-eclampsia (14%). Lower eGFR (OR 0.98; p = 0.05) and higher uPCR (OR 1.86; p = 0.02) at conception were independent predictors for poor composite obstetric outcome. Lower eGFR (OR 0.98; p = 0.04), higher uPCR (OR 1.50; p = 0.04), and live organ donation (OR 0.35; p = 0.02) were predictors of ≥20% loss of eGFR between immediately pre-pregnancy and one yr after delivery. There was no difference in eGFR at one, five, and 10 yr in pregnant women compared with non-pregnant controls and a pregnancy was not associated with poorer 10-yr transplant or 20-yr patient survival. Despite high rates of obstetric complications, most women had successful pregnancies with good long-term transplant function., (© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
10. Early pregnancy soluble E-selectin concentrations and risk of preeclampsia.
- Author
-
Carty DM, Anderson LA, Freeman DJ, Welsh PI, Brennand JE, Dominiczak AF, and Delles C
- Published
- 2012
- Full Text
- View/download PDF
11. Human parvovirus B19 in pregnancy
- Author
-
Brennand, JE and Cameron, AD
- Abstract
Parvovirus B19 infection can result in an adverse outcome when acquired during pregnancy. However, in the majority of cases a successful outcome can be anticipated. Public awareness of this condition is essential and obstetricians should be familiar with the options available to them if they are presented with this clinical problem.
- Published
- 2000
- Full Text
- View/download PDF
12. Urinary proteomics for prediction of preeclampsia.
- Author
-
Carty DM, Siwy J, Brennand JE, Zürbig P, Mullen W, Franke J, McCulloch JW, Roberts CT, North RA, Chappell LC, Mischak H, Poston L, Dominiczak AF, and Delles C
- Subjects
- Adult, Biomarkers analysis, Biomarkers urine, Chromatography, Liquid, Female, Humans, Mass Spectrometry, Predictive Value of Tests, Pregnancy, Proteomics, Pre-Eclampsia diagnosis, Pre-Eclampsia urine
- Abstract
Preeclampsia is a major determinant of fetal and maternal morbidity and mortality. We used a proteomic strategy to identify urinary biomarkers that predict preeclampsia before the onset of disease. We prospectively collected urine samples from women throughout pregnancy. Samples from gestational weeks 12 to 16 (n=45), 20 (n=50), and 28 (n=18) from women who subsequently had preeclampsia develop were matched to controls (n=86, n=49, and n=17, respectively). We performed capillary electrophoresis online coupled to micro-time-of-flight mass spectrometry. Disease-specific peptide patterns were generated using support vector machine-based software. Candidate biomarkers were sequenced by liquid chromatography-tandem mass spectrometry. From comparison with nonpregnant controls, we defined a panel of 284 pregnancy-specific proteomic biomarkers. Subsequently, we developed a model of 50 biomarkers from specimens obtained at week 28 that was associated with future preeclampsia (classification factor in cases, 1.032 ± 0.411 vs controls, -1.038 ± 0.432; P<0.001). Classification factor increased markedly from week 12 to 16 to 28 in women who subsequently had preeclampsia develop (n=16; from -0.392 ± 0.383 to 1.070 ± 0.383; P<0.001) and decreased slightly in controls (n=16; from -0.647 ± 0.437 to -1.024 ± 0.433; P=0.043). Among the biomarkers are fibrinogen alpha chain, collagen alpha chain, and uromodulin fragments. The markers appear to predict preeclampsia at gestational week 28 with good confidence but not reliably at earlier time points (weeks 12-16 and 20). After prospective validation in other cohorts, these markers may contribute to better prediction, monitoring, and accurate diagnosis of preeclampsia.
- Published
- 2011
- Full Text
- View/download PDF
13. Fetal Heart — Abnormal Appearances
- Author
-
Brennand, JE and Macara, LM
- Published
- 1999
- Full Text
- View/download PDF
14. Production of inhibin forms by the fetal membranes, decidua, placenta and fetus at parturition.
- Author
-
Riley SC, Leask R, Balfour C, Brennand JE, and Groome NP
- Subjects
- Amnion metabolism, Amniotic Fluid metabolism, Chorion metabolism, Culture Techniques, Female, Fetal Blood metabolism, Gestational Age, Humans, Inhibins blood, Inhibins urine, Labor, Obstetric, Lung embryology, Lung physiology, Male, Perfusion, Pregnancy, Protein Isoforms, Decidua metabolism, Extraembryonic Membranes metabolism, Fetus metabolism, Inhibins metabolism, Placenta metabolism
- Abstract
Inhibins are regulators of paracrine and endocrine function during pregnancy, but their intrauterine sites of secretion are not well established. In amniotic fluid, inhibin A-, inhibin B- and inhibin pro-alphaC-containing isoforms were present in high concentrations, whereas in maternal serum, inhibin A and pro-alphaC forms were present in high amounts, with low concentrations of inhibin B. In fetal cord serum, inhibin pro-alphaC was present in all samples, inhibin B was detectable in male but not female fetuses, with no detectable inhibin A in either sex. From cultured explants, both inhibin A and B were secreted by chorion laeve, whereas only inhibin A was secreted by placenta, with both tissues secreting inhibin pro-alphaC. Only low concentrations of both dimeric inhibins and pro-alphaC forms were secreted by decidua parietalis and amnion. The dual perfused placental cotyledon secreted both inhibin A and pro-alphaC into maternal perfusate, but only inhibin pro-alphaC into the fetal circulation and less than to the maternal side. We conclude that trophoblast is the predominant source of dimeric inhibins, but with markedly different secretion depending on its intrauterine location. There was a significant decrease in inhibin A and pro-alphaC in amniotic fluid collected at term active labour compared to elective Caesarean section (P < 0.001). This may reflect a local change in inhibin/activin processing at labour, likely in chorion laeve trophoblast cells, which may be important in the paracrine control of the feto-maternal communication required to maintain pregnancy and initiate labour.
- Published
- 2000
- Full Text
- View/download PDF
15. Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin.
- Author
-
Brennand JE, Walker ID, and Greer IA
- Subjects
- Adult, Anticoagulants pharmacokinetics, Enoxaparin pharmacokinetics, Female, Humans, Pregnancy, Anticoagulants therapeutic use, Enoxaparin therapeutic use, Factor Xa analysis, Pregnancy Complications, Hematologic prevention & control, Thrombosis prevention & control
- Published
- 1999
- Full Text
- View/download PDF
16. The effects of mifepristone on cervical ripening and labor induction in primigravidae.
- Author
-
Elliott CL, Brennand JE, and Calder AA
- Subjects
- Adolescent, Adult, Double-Blind Method, Female, Gravidity, Humans, Hypoglycemia chemically induced, Infant, Newborn, Maternal-Fetal Exchange, Mifepristone administration & dosage, Mifepristone adverse effects, Pregnancy, Risk Factors, Cervical Ripening drug effects, Labor, Induced methods, Mifepristone pharmacology
- Abstract
Objective: To compare the effects of 50 mg or 200 mg of oral mifepristone with placebo on cervical ripening and induction of labor in primigravid women at term with unfavorable cervices., Methods: This was a double-blind study in which 80 primigravidae at term with a modified Bishop score of 4 or less were randomly assigned to one of three treatment groups. They were assessed at 24-hour intervals for 72 hours, after which labor was induced if it had not occurred spontaneously., Results: Two hundred milligrams of mifepristone resulted in a favorable cervix (with a Bishop score greater than 6 or in spontaneous labor) in significantly more women than placebo (P = .01). An improvement in cervical ripening was seen in the group given 50 mg of mifepristone, but this was not statistically significant. There were more cesarean deliveries performed for fetal distress in the group treated with 200 mg of mifepristone than placebo, but this was not statistically significant and was not associated with any differences between groups in terms of neonatal outcome., Conclusion: Mifepristone, a progesterone antagonist, is known to cause softening and dilation of the human early pregnant cervix and an increase in uterine activity. It is theoretically attractive for use as an adjunct in cervical priming and labor induction. In this study, 200 mg of mifepristone was significantly more likely to result in a favorable cervix than placebo.
- Published
- 1998
- Full Text
- View/download PDF
17. Mechanisms involved in the stimulatory effect of amniotic fluid on prostaglandin production by human fetal membranes.
- Author
-
Brennand JE, Leask R, Kelly RW, Greer IA, and Calder AA
- Subjects
- Amniotic Fluid cytology, Cells, Cultured, Cesarean Section, Chorion cytology, Chorion drug effects, Cycloheximide pharmacology, Dactinomycin pharmacology, Dinoprost analogs & derivatives, Dinoprost biosynthesis, Dinoprost metabolism, Dinoprostone analogs & derivatives, Dinoprostone biosynthesis, Enzyme Inhibitors pharmacology, Extraembryonic Membranes cytology, Extraembryonic Membranes drug effects, Female, Genistein pharmacology, Humans, Labor, Obstetric, Pregnancy, Staurosporine pharmacology, Amniotic Fluid physiology, Extraembryonic Membranes metabolism, Prostaglandins biosynthesis
- Abstract
This study aims to investigate potential mechanisms involved in the stimulatory effect of amniotic fluid on prostaglandin production by fetal membranes. A cell culture study of amnion and chorion was obtained following elective caesarean section, incubated with amniotic fluid collected at term (37-42 weeks' gestation) following either spontaneous labour (n = 6) or elective caesarean section (n = 6). The effect of addition of cycloheximide and actinomycin D (inhibitors of translation and transcription respectively), and staurosporine and genistein (inhibitors of protein kinase C and tyrosine kinase respectively) to these cultures was investigated. ANOVA was employed for statistical analysis. Cycloheximide and staurosporine significantly inhibited the stimulatory effect of spontaneous labour and elective section amniotic fluid on PGE2 production by amnion, and PGEM production by chorion. Genistein significantly inhibited the stimulatory effect of spontaneous labour amniotic fluid on PGE2 and PGEM production by amnion and chorion respectively. The stimulatory effect of amniotic fluid on prostaglandin production is dependent on new protein synthesis, presumably cyclooxygenase (COX), and stimulation of cell signal transduction pathways involving protein kinase C and tyrosine kinase.
- Published
- 1998
- Full Text
- View/download PDF
18. Recombinant human relaxin as a cervical ripening agent.
- Author
-
Brennand JE, Calder AA, Leitch CR, Greer IA, Chou MM, and MacKenzie IZ
- Subjects
- Administration, Intravaginal, Adult, Cervix Uteri physiology, Dose-Response Relationship, Drug, Double-Blind Method, Female, Gels, Humans, Labor Stage, First, Pregnancy, Recombinant Proteins administration & dosage, Recombinant Proteins adverse effects, Cervix Uteri drug effects, Labor, Induced methods, Oxytocics administration & dosage, Oxytocics adverse effects, Relaxin administration & dosage, Relaxin adverse effects
- Abstract
Objective: The aim of this study was to investigate the efficacy and safety of recombinant human relaxin (rhRIx) as a cervical ripening agent in women with an unfavourable cervix before induction of labour at term., Design: A multi-centre, double-blind, placebo-controlled trial performed in Edinburgh, Glasgow and Oxford. Women were treated with 0, 1, 2 or 4 mg of rhRIx in a gel vehicle administered intravaginally. Analysis of variance tests were performed on all continuous variables, and Cochran Mantel-Haenszel tests employed for all discrete variables., Participants: Ninety-six women at 37 to 42 weeks of gestation with a singleton pregnancy and a modified Bishop score of < or = 4 were recruited., Results: There was no significant difference in the change in modified Bishop score between the four treatment groups. The lengths of the first and second stages of labour were similar in all 4 groups. PGE2 and oxytocin requirements were similar in all groups, as was the mode of delivery. There was no evidence that relaxin was absorbed systemically when given in this way., Conclusion: Recombinant human relaxin 1 to 4 mg, administered as an intravaginal gel, has no effect as a cervical ripening agent before induction of labour at term.
- Published
- 1997
- Full Text
- View/download PDF
19. Prawn sandwiches, red herrings and abdominal pregnancy.
- Author
-
Brennand JE, Morris AR, and Greer IA
- Subjects
- Adult, Blood Transfusion, Fallopian Tubes surgery, Female, Fetal Death, Gestational Age, Humans, Hysterectomy, Pregnancy, Pregnancy, Ectopic surgery, Pregnancy, Ectopic diagnosis, Uterus abnormalities
- Abstract
An unusual presentation of abdominal pregnancy is reported. The difficulty in diagnosis of this form of ectopic pregnancy, and the potential risks of delayed intervention are highlighted. The association with uterine anomaly, in this case uterus didelphys, is discussed.
- Published
- 1997
- Full Text
- View/download PDF
20. Changes in prostaglandin synthesis and metabolism associated with labour, and the influence of dexamethasone, RU 486 and progesterone.
- Author
-
Brennand JE, Leask R, Kelly RW, Greer IA, and Calder AA
- Subjects
- Amnion drug effects, Amnion metabolism, Amnion physiology, Analysis of Variance, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Arachidonic Acids pharmacology, Chorion drug effects, Chorion metabolism, Chorion physiology, Culture Techniques, Dinoprost biosynthesis, Dinoprost metabolism, Dinoprostone biosynthesis, Dinoprostone metabolism, Female, Humans, Indomethacin pharmacology, Labor, Obstetric physiology, Pregnancy, Radioimmunoassay, Tetradecanoylphorbol Acetate pharmacology, Anti-Inflammatory Agents pharmacology, Dexamethasone pharmacology, Hormone Antagonists pharmacology, Labor, Obstetric metabolism, Mifepristone pharmacology, Progesterone pharmacology, Prostaglandins biosynthesis, Prostaglandins metabolism
- Abstract
The objective was to compare the changes in prostaglandin synthesis and metabolism occurring within the fetal membranes that are associated with the onset of parturition and to study the effect of steroid hormones on prostaglandin metabolism. A tissue explant study was made of discs of amnion and chorion obtained from 24 pregnant women at 37-42 weeks' gestation following spontaneous labour and delivery (12 women) and elective caesarean section (12 women). Significantly more prostaglandin E2 (PGE2) and PGF2 alpha were synthesized by amnion obtained following spontaneous labour than elective caesarean section. Arachidonic acid stimulated both PGE2 and PGF2 alpha synthesis by amnion in both groups. Phorbol myristoyl acetate stimulated PGE2 synthesis in both groups. There was no difference between the groups in the capacity of the chorion to metabolize prostaglandins. Mifepristone (RU 486) reduced the metabolism of added PGE2 following spontaneous labour, while dexamethasone and progesterone had no effect on prostaglandin metabolism. In conclusion, the increase in concentration of PGE2 and PGF2 alpha associated with the onset of spontaneous labour is the result of an increase in synthesis rather than a reduction in metabolism. There was no decrease in metabolism to account for the increase in prostaglandin concentrations and, with the exception of mifepristone, metabolism was not altered by the addition of steroid hormones.
- Published
- 1995
- Full Text
- View/download PDF
21. Effects of gemeprost and mifepristone on the mechanical properties of the cervix prior to first trimester termination of pregnancy.
- Author
-
Carbonne B, Brennand JE, Maria B, Cabrol D, and Calder AA
- Subjects
- Abortifacient Agents, Nonsteroidal adverse effects, Administration, Oral, Adolescent, Adult, Alprostadil administration & dosage, Alprostadil adverse effects, Female, Humans, Mifepristone adverse effects, Obstetrics instrumentation, Pessaries, Pregnancy, Pregnancy Trimester, First, Abortifacient Agents, Nonsteroidal administration & dosage, Abortion, Induced, Alprostadil analogs & derivatives, Cervix Uteri drug effects, Mifepristone administration & dosage
- Abstract
Objective: To study the effects of oral mifepristone and vaginal gemeprost on the mechanical properties of the cervix prior to first trimester termination of pregnancy by vacuum aspiration., Design: A comparative study. Each patient served as her own control., Setting: The Royal Infirmary of Edinburgh, Scotland, UK., Subjects: Forty nulliparous women at six to twelve weeks of pregnancy., Interventions: The women received either gemeprost (1 mg) 3 h prior to termination of pregnancy or mifepristone (200 mg) 48 h before operation., Main Outcome Measures: Two different objective methods of assessment of the mechanical properties of the cervix, one measuring the distensibility of the cervix before drug administration and immediately before the operation, and the other measuring the force necessary to dilate the cervix; incidence of new symptoms following drug intake; immediate complications and estimated blood loss., Results: Both treatments significantly increased cervical distensibility. Baseline dilatation was greater in the mifepristone group. The force required to dilate the cervix was significantly reduced in mifepristone-treated patients. There was a good correlation between the two different methods of assessment of the mechanical properties of the cervix only in the gemeprost group., Conclusion: Cervagem and mifepristone can be used to increase cervical distensibility. Cervical dilatation is easier with a 48 h regimen of mifepristone than with gemeprost.
- Published
- 1995
- Full Text
- View/download PDF
22. Unexplained haemolytic anaemia in successive pregnancies with negative direct antiglobulin test and response to high dose i.v. IgG.
- Author
-
Bjornsson S, Brennand JE, Calder AA, Lumley SP, Manson L, Todd AA, Murphy WG, and Ludlam CA
- Subjects
- Adult, Anemia, Hemolytic etiology, Blood Transfusion, Coombs Test, Female, Humans, Infusions, Intravenous, Pregnancy, Pregnancy Complications, Hematologic etiology, Anemia, Hemolytic therapy, Immunoglobulin G administration & dosage, Pregnancy Complications, Hematologic therapy
- Published
- 1994
- Full Text
- View/download PDF
23. Interleukin-8 production by the human cervix.
- Author
-
Barclay CG, Brennand JE, Kelly RW, and Calder AA
- Subjects
- Abortifacient Agents, Nonsteroidal pharmacology, Alprostadil analogs & derivatives, Alprostadil pharmacology, Analysis of Variance, Cervix Uteri drug effects, Culture Techniques, Dimethylformamide pharmacology, Dinoprostone biosynthesis, Ethers, Cyclic pharmacology, Female, Humans, Lipopolysaccharides pharmacology, Okadaic Acid, Phosphoprotein Phosphatases antagonists & inhibitors, Progesterone pharmacology, Radioimmunoassay, Tetradecanoylphorbol Acetate pharmacology, Tumor Necrosis Factor-alpha pharmacology, Cervix Uteri metabolism, Interleukin-8 biosynthesis, Menopause metabolism, Pregnancy metabolism
- Abstract
Objectives: Our purpose was (1) to determine whether the human cervix is capable of producing interleukin-8 in vitro and to examine the possibility of stimulating an increase in any such output and (2) to examine the concomitant production of prostaglandins., Study Design: Cervical tissue was obtained from 48 women, 29 pregnant women undergoing surgical termination of pregnancy (20 of whom were treated with the prostaglandin analog Cervagem), 14 nonpregnant, premenopausal women, and three postmenopausal women. Explants were cultured and the medium was assayed for interleukin-8 and prostaglandin E2. Analysis of variance and Newman-Keuls statistical tests were used., Results: Significant quantities of interleukin-8 were produced by the tissue, and the data indicate that cervical explants from pregnant and nonpregnant women behave in a similar way when challenged by phorbol myristate acetate but that the postmenopausal cervix loses its capacity for interleukin-8 production., Conclusions: Human cervix is capable of producing large amounts of interleukin-8 in vitro, and it may be influenced by the steroid hormones. Thus interleukin-8 could be an excellent candidate for a prime role in neutrophil-mediated cervical ripening.
- Published
- 1993
- Full Text
- View/download PDF
24. Labor and normal delivery: induction of labor.
- Author
-
Brennand JE and Calder AA
- Subjects
- Cervix Uteri drug effects, Clinical Trials as Topic, Female, Fetal Membranes, Premature Rupture drug therapy, Humans, Labor, Induced standards, Mifepristone adverse effects, Mifepristone pharmacology, Mifepristone therapeutic use, Oxytocin administration & dosage, Oxytocin pharmacology, Oxytocin therapeutic use, Pregnancy, Prostaglandins administration & dosage, Prostaglandins pharmacology, Prostaglandins therapeutic use, Labor, Induced methods
- Abstract
The continuing search for improvements in the methods of labor induction has seen the development of techniques that are more efficient, more reliable, safer, and more acceptable to the patient. Ultimately, these objectives will be best served by striving to mimic the normal physiology of parturition as closely as possible. Attention must be paid to the control of cervical ripening as well as myometrial contractility. Refinements in the use of oxytocin and prostaglandins continue to produce better results and the dawning of the era of progesterone receptor blockers gives hope of further significant advances.
- Published
- 1991
25. MIFEPRISTON IN OBSTETRICS – WHY NOT?
- Author
-
Melia, Larisa, Sulukhia, Revaz, Pkhaladze, Lali, Davidova, Nino, and Khomasuridze, Archil
- Published
- 2024
26. Welche Rolle spielt das Geschlecht bei der Nierentransplantation?
- Author
-
Altuner, Ugur, Siam, Sami, Jehn, Ulrich, Suwelack, Barbara, and Reuter, Stefan
- Abstract
Copyright of Die Nephrologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
27. Maternal and neonatal outcomes in kidney transplant recipients: a single-center observational study.
- Author
-
Artan AS, Mirioglu S, Ünal E, Suleymanova V, Akin Oto O, Ozturk S, Yazici H, Saraç Sivrikoz T, and Turkmen A
- Abstract
Objective: Pregnancy poses a high risk for adverse maternal and neonatal outcomes in kidney transplant recipients (KTRs), and data on long-term allograft functions compared to the healthy population are still limited. Therefore, we aimed to conduct a comparative analysis of maternal and neonatal outcomes in KTRs., Subject and Methods: In this retrospective single-center study, KTRs who experienced pregnancy after transplantation were evaluated in comparison with an age-matched non-transplanted control group. Maternal outcomes included obstetric complications (preeclampsia, peripartum hemorrhage, duration of maternal hospitalization) and a composite kidney outcome for KTRs defined as progression to graft failure necessitating dialysis or retransplantation or doubling of serum creatinine at the end of follow-up. Neonatal outcomes were gestational age, preterm birth, newborn mortality, admittance to the neonatal intensive care unit (NICU), Apgar scores, and birth weight., Results: In 53 KTRs, 68 pregnancies occurred. Preeclampsia (p < 0.001) and preterm birth (p = 0.003) were significantly higher in KTRs. The KTR pregnancies had lower mean birth weights (p = 0.001) and longer durations of maternal hospitalization (p = 0.001). Neonatal mortality, NICU admissions, peripartum hemorrhage rates, and Apgar scores were similar between groups. Follow-up for a median of 105 months after the index birth showed higher serum creatinine levels at postpartum visits (p < 0.001) and at the last follow-up (p = 0.001) compared to baseline. Of the KTRs 6 (11.3%) experienced composite kidney outcomes, including 5 patients with graft failure and 1 with a doubling of serum creatinine., Conclusion: The KTRs exhibit comparable neonatal mortality and NICU admission rates but have higher rates of preeclampsia and preterm birth. Importantly, graft functions worsen significantly during postpartum follow-up., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
28. Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial.
- Author
-
Romero R, Meyyazhagan A, Hassan SS, Creasy GW, and Conde-Agudelo A
- Subjects
- Humans, Female, Pregnancy, Administration, Intravaginal, Randomized Controlled Trials as Topic, Cervical Length Measurement, Infant, Newborn, Respiratory Distress Syndrome, Newborn prevention & control, Progesterone administration & dosage, Progesterone therapeutic use, Premature Birth prevention & control, Cervix Uteri diagnostic imaging, Progestins administration & dosage, Progestins therapeutic use
- Abstract
The PREGNANT trial was a randomized, placebo-controlled, multicenter trial designed to determine the efficacy and safety of vaginal progesterone (VP) to reduce the risk of birth < 33 weeks and of neonatal complications in women with a sonographic short cervix (10 to 20 mm) in the mid-trimester (19 to 23 6/7 wk). Patients allocated to receive VP had a 45% lower rate of preterm birth (8.9% vs 16.1%; relative risk = 0.55; 95% CI: 0.33-0.92). Neonates born to mothers allocated to VP had a 60% reduction in the rate of respiratory distress syndrome. This article reviews the background, design, execution, interpretation, and impact of the PREGNANT Trial.
- Published
- 2024
- Full Text
- View/download PDF
29. Successful pregnancies in post-kidney transplant couples: four case reports.
- Author
-
Hao Huang, Xinyu Liu, Xiaoli Lin, Xiaoying Wu, Yingyin Qiu, and Hongfeng Huang
- Subjects
ECLAMPSIA ,FERTILIZATION in vitro ,LOW birth weight ,CESAREAN section ,PREGNANCY ,PREMATURE labor - Abstract
Background: The fertility of female kidney transplant recipients is increasing with the progression of transplant management. This article aims to evaluate the clinical prognosis of mothers and newborns for post-kidney transplant couples Methods: From January 2019 to April 2022, a total of four couples, all kidney transplant recipients, were successfully prepared for pregnancy after a rigorous preconception evaluation, including three cases of natural conception and one case of in vitro fertilization. Data regarding the mother and newborn, including general clinical condition and laboratory results, were recorded and assessed throughout the pregnancy and up until 12 months after delivery Results: The mean conception age of the mothers was 34.8 years (30-38 years), and the mean interval between renal transplantation and pregnancy was 6.6 years (3.7-8.7 years). All deliveries were by cesarean section and took place without incident. There were three premature births (<37 weeks; average 35.1 weeks). In case 1 (in vitro fertilization), pre-eclampsia occurred during maternity, and this was the only case in which the fetal weight was less than 2,500 g (average 2,576.7 g). The mean Apgar score (1 min) was 7.8 (6-9) and reached 9 in all cases at 5 min. The mothers' eGFR rose during mid-gestation, decreased in late pregnancy, and was largely restored along with proteinuria 1 year postpartum. Postnatal evaluation at 6 months showed normal neurological development. In addition, NK cell and IFN-g levels increased and Treg cell and IL-10 levels decreased along with the onset of pre-eclampsia Conclusions: Pregnancies can succeed in couples who are both kidney transplant recipients. However, there might be higher risks of infertility, prematurity, and low birth weight. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions.
- Author
-
Gupta, Anjali, Gautam, Sarika, Chanana, Shelly, Sangwan, Neetu, Singhal, Savita Rani, Anand, Smriti, and Dahiya, Sonia
- Subjects
ABORTION ,MISOPROSTOL ,CHI-squared test ,INTRAVAGINAL administration ,MIFEPRISTONE ,UTERINE rupture - Abstract
Objective: Comparison of two different intervals of misoprostol administration after mifepristone in second trimester abortions. Materials and methods: This 12-month prospective study was conducted at a tertiary care facility. Only pregnancies with congenital deformity or sterilisation failure were included in the study's recruitment of 100 women who visited the hospital for a second trimester abortion between 12 and 20 weeks; cases with scarred uteri were omitted. In a systematic random selection of 50 women in each group, the administration of 200 mg of mifepristone orally was followed by two distinct intervals of intravaginal misoprostol administration at 24- and 48-hour intervals. After 24 hours, group A women received intravaginal 400 mcg misoprostol three hourly, up to a maximum of five doses, while group B received the same doses after 48 hours. Induction abortion interval noted on various parameters and paired t test and chi square test applied. Results: The mean IAI following misoprostol administration was 8.14 2±.03 hours in group A and 7.71 ±2.56 hours in group B. This difference was statistically insignificant. Average misoprostol doses for group A were 1.68±0.71 and for the group, B were 1.68±0.84; both doses were found to be statistically insignificant when used to induce abortion. All women aborted successfully in each group. There was no significant difference in side effects in both groups. Conclusion: Based on the results it was observed that shorter interval between mifepristone and misoprostol i.e., 24 hours can be chosen to decrease the hospital stay as there was no significant difference was seen after intravaginal misoprostol in terms of induction abortion interval, number of doses and side effects. [ABSTRACT FROM AUTHOR]
- Published
- 2023
31. Counselling on Conceiving: Attitudes and Factors Influencing Advice of Professionals in Transplantation.
- Author
-
van Buren, Marleen C., Gosselink, Margriet, Massey, Emma K., van de Wetering, Jacqueline, and Lely, A. Titia
- Subjects
COUNSELING ,PREGNANCY outcomes ,RISK perception ,KIDNEY transplantation ,ADVICE - Abstract
Pregnancy after kidney transplantation (KT) conveys risks of adverse pregnancy outcomes (APO). Little is known about performance of pre-pregnancy counselling after KT. This study investigated perceptions of risk, attitudes towards pregnancy and factors influencing advice given at pre-pregnancy counselling after KT. A web-based vignette survey was conducted among nephrologists and gynaecologists between March 2020 and March 2021, consisting of five vignettes containing known risk factors for APO and general questions on pre-pregnancy counselling after KT. Per vignette, attitudes towards pregnancy and estimation of outcomes were examined. In total 52 nephrologists and 25 gynaecologists participated, 56% from university hospitals. One third had no experience with pregnancy after KT. All gave positive pregnancy advice in the vignette with ideal circumstances (V1), versus 83% in V2 (proteinuria), 81% in V3 (hypertension), 71% in V4 (eGFR 40 ml/min/1.73 m²). Only 2% was positive in V5 (worst-case scenario). Chance of preeclampsia was underestimated by 89% in V1. 63% and 98% overestimated risk for graft loss in V4 and V5. Professionals often incorrectly estimated risk of APO after KT. As experience with pregnancy after KT was limited among professionals, patients should be referred to specialised centres for multidisciplinary pre-pregnancy counselling to build experience and increase consistency in given advice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Role of Uromodulin in Salt-Sensitive Hypertension.
- Author
-
Mary, Sheon, Boder, Philipp, Padmanabhan, Sandosh, McBride, Martin W., Graham, Delyth, Delles, Christian, and Dominiczak, Anna F.
- Published
- 2022
- Full Text
- View/download PDF
33. Potential urinary biomarkers in preeclampsia: a narrative review.
- Author
-
Avendanha RA, Campos GFC, Branco BC, Ishii NC, Gomes LHN, de Castro AJ, Leal CRV, and Simões E Silva AC
- Subjects
- Pregnancy, Infant, Newborn, Female, Humans, Placenta Growth Factor, Kidney, Biomarkers, Pre-Eclampsia diagnosis, Urinary Tract
- Abstract
Introduction: Preeclampsia (PE) is a highly relevant pregnancy-related disorder. An early and accurate diagnosis is crucial to prevent major maternal and neonatal complications and mortality. Due to the association of kidney dysfunction with the pathophysiology of the disease, urine samples have the potential to provide biomarkers for PE prediction, being minimally invasive and easy to perform. Therefore, searching for novel biomarkers may improve outcomes. This narrative review aimed to summarize the scientific literature about the traditional and potential urinary biomarkers in PE and to investigate their applicability to screen and diagnose the disorder., Methods: A non-systematic search was performed in PubMed/MEDLINE, Scopus, and SciELO databases., Results: There is significant divergence in the literature regarding traditionally used serum markers creatinine, cystatin C, and albuminuria, accuracy in PE prediction. As for the potential renal biomarkers investigated, including vascular epithelial growth factor (VEGF), placental growth factor (PlGF), and soluble fms-like tyrosine kinase (sFlt-1), urinary levels of PlGF and sFtl-1/PlGF ratio in urine seem to be the most promising as screening tests. The assessment of the global load of misfolded proteins through urinary congophilia, podocyturia, and nephrinuria has also shown potential for screening and diagnosis. Studies regarding the use of proteomics and metabolomics have shown good accuracy, sensitivity, and specificity for predicting the development and severity of PE., Conclusion: However, there are still many divergences in the literature, which requires future and more conclusive research to confirm the predictive role of urinary biomarkers in pregnant women with PE., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF
34. The Strategy for Peptidomic LC-MS/MS Data Analysis: The Case of Urinary Peptidome Study.
- Author
-
Zakharova NV, Bugrova AE, Indeykina MI, Brzhozovskiy AG, Nikolaev EN, and Kononikhin AS
- Subjects
- Humans, Male, Female, Pregnancy, Chromatography, Liquid, Proteins, Peptides metabolism, Proteomics methods, Tandem Mass Spectrometry methods, Liquid Chromatography-Mass Spectrometry
- Abstract
The study of urinary peptidome is an important area of research, which concerns the characterization of endogenous peptides, as well as the identification of biomarkers for a wide range of socially significant diseases. First of all, this relates to renal and genitourinary pathologies and/or pathologies associated with proteinuria, such as kidney diseases, bladder, prostate and ovarian cancers, diabetic nephropathy, and pre-eclampsia. Unlike proteins, peptides do not require proteolytic hydrolysis, can be analyzed in their native form and can provide certain information about occurring (patho)physiological processes. Mass spectrometry (MS)-based approaches are the most unbiased and sensitive instruments with high multiplexing capacity and provided most of the current information about endogenous urine peptides. However, despite the large number of urine peptidomic studies, there are certain issues related to the insufficient comparability of their results due to the lack of consistent approaches to their interpretation. Also the development of a custom project-specific protein library for endogenous peptides search and identification is another important point that should be noted in the context of high-throughput peptidomic analysis. Here we propose the custom-specific urinary protein database and the grouping of endogenous urinary peptides with overlapping sequences as useful tools, which can facilitate the acquisition and analysis of LC-MS peptidomic data, as well as the comparison of results of different studies, which should facilitate their more efficient further application., (© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
35. Quantitative urine proteomics in pregnant women for the identification of predictive biomarkers for preeclampsia.
- Author
-
Joenväärä, Sakari, Holm, Matilda, Saraswat, Mayank, Agarwal, Rahul, Tohmola, Tiialotta, Kajantie, Eero, Räikkönen, Katri, Laivuori, Hannele, Villa, Pia M., Hämäläinen, Esa, and Renkonen, Risto
- Published
- 2022
- Full Text
- View/download PDF
36. Evaluation of the obstetric anaesthesia procedures at Mater Dei Hospital in 2019.
- Author
-
Abela, Glenn Paul, Thornton, Benjamin, Cortis, Petramay Attard, and Calleja, Paul
- Subjects
ANESTHESIA ,CESAREAN section ,MATERNITY nursing ,EPIDURAL catheters ,PREGNANT women ,ANESTHETICS ,EPIDURAL analgesia ,PERIPHERALLY inserted central catheters - Abstract
INTRODUCTION The aim of this retrospective study was to investigate all obstetric anaesthesia procedures at Mater Dei Hospital (MDH) in 2019 to better understand the care provided by anaesthetists to parturients. METHODOLOGY Data was collected from the obstetric anaesthesia logbook, a paper record in which the duty anaesthetist at the Central Delivery Suite (CDS) lists all anaesthetic interventions carried out over the previous 24 hours. All procedures were entered into a spreadsheet and coded. Calculations were then carried out to work out five parameters: the Caesarean section rate, the epidural uptake rate, the regional anaesthesia rate, the anaesthetic intervention number, and the Obstetric Anaesthesia Activity Index (OAAI). RESULTS There were 4040 deliveries at MDH in 2019. 1194 lower segment Caesarean sections (LSCS) were recorded in the obstetric anaesthesia logbook and the Caesarean section rate was 29.6%. A total of 966 spinal anaesthetics were carried out, 907 (94%) of which were for a LSCS. 1064 epidural catheters were inserted for labour analgesia, with a 26.3% epidural uptake rate for 2019. There were 109 parturients who required a general anaesthetic. The anaesthetic intervention number was 2350 and the Obstetric Anaesthesia Activity Index was 7.09. CONCLUSION The parameters listed above are described and compared to international guidelines and other descriptive studies. With 2350 anaesthetic interventions in obstetrics, anaesthetists were actively involved in the care of over half of all parturients at MDH in 2019 and this confirms the wide and considerable role anaesthetics has in maternal services provided at MDH. [ABSTRACT FROM AUTHOR]
- Published
- 2022
37. Preterm labor is characterized by a high abundance of amniotic fluid prostaglandins in patients with intra-amniotic infection or sterile intra-amniotic inflammation.
- Author
-
Peiris, Hassendrini N., Romero, Roberto, Vaswani, Kanchan, Reed, Sarah, Gomez-Lopez, Nardhy, Tarca, Adi L., Gudicha, Dereje W., Erez, Offer, Maymon, Eli, and Mitchell, Murray D.
- Subjects
CHORIOAMNIONITIS ,AMNIOTIC liquid ,PREMATURE labor ,LIQUID chromatography-mass spectrometry ,PROSTAGLANDINS - Abstract
Objective: To distinguish between prostaglandin and prostamide concentrations in the amniotic fluid of women who had an episode of preterm labor with intact membranes through the utilisation of liquid chromatography-tandem mass spectrometry.Study Design: Liquid chromatography-tandem mass spectrometry analysis of amniotic fluid of women with preterm labor and (1) subsequent delivery at term (2) preterm delivery without intra-amniotic inflammation; (3) preterm delivery with sterile intra-amniotic inflammation (interleukin (IL)-6>2.6 ng/mL without detectable microorganisms); and (4) preterm delivery with intra-amniotic infection [IL-6>2.6 ng/mL with detectable microorganisms].Results: (1) amniotic fluid concentrations of PGE2, PGF2α, and PGFM were higher in patients with intra-amniotic infection than in those without intra-amniotic inflammation; (2) PGE2 and PGF2α concentrations were also greater in patients with intra-amniotic infection than in those with sterile intra-amniotic inflammation; (3) patients with sterile intra-amniotic inflammation had higher amniotic fluid concentrations of PGE2 and PGFM than those without intra-amniotic inflammation who delivered at term; (4) PGFM concentrations were also greater in women with sterile intra-amniotic inflammation than in those without intra-amniotic inflammation who delivered preterm; (5) amniotic fluid concentrations of prostamides (PGE2-EA and PGF2α-EA) were not different among patients with preterm labor; (6) amniotic fluid concentrations of prostaglandins, but no prostamides, were higher in cases with intra-amniotic inflammation; and (7) the PGE2:PGE2-EA and PGF2α:PGF2α-EA ratios were higher in patients with intra-amniotic infection compared to those without inflammation.Conclusions: Mass spectrometric analysis of amniotic fluid indicated that amniotic fluid concentrations of prostaglandins, but no prostamides, were higher in women with preterm labor and intra-amniotic infection than in other patients with an episode of preterm labor. Yet, women with intra-amniotic infection had greater amniotic fluid concentrations of PGE2 and PGF2α than those with sterile intra-amniotic inflammation, suggesting that these two clinical conditions may be differentiated by using mass spectrometric analysis of amniotic fluid. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
38. Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension.
- Author
-
Boder, Philipp, Mary, Sheon, Mark, Patrick B., Leiper, James, Dominiczak, Anna F., Padmanabhan, Sandosh, Rampoldi, Luca, and Delles, Christian
- Published
- 2021
- Full Text
- View/download PDF
39. Transcriptomic profile of VEGF-regulated genes in human cervical epithelia.
- Author
-
Johnson, MacKinsey and Mowa, Chishimba Nathan
- Subjects
HUMAN genes ,WATER-electrolyte balance (Physiology) ,RNA sequencing ,PSEUDOGENES ,NON-coding RNA - Abstract
Cervical epithelial cells play a central role in cervical remodeling (CR) during pregnancy and cervical events during menstrual cycle, including mounting physical and immunological barriers, proliferation and differentiation, maintenance of fluid balance, and likely in withstanding the mechanical force exerted by the growing fetus prior to term. In the present study, we attempt to decipher the specific roles of VEGF in fetal human cervical epithelial cells by delineating VEGF signature genes using RNA sequencing in order to characterize the specific biological effects of VEGF in these cells. Out of a total of 25,000 genes screened, 162 genes were found to be differentially expressed in human cervical epithelial cells, of which 12 genes were found to be statistically significantly differentially expressed. The differentially expressed genes (162) were categorized by biological function, which included (1) proliferation, (2) immune response, (3) structure/matrix, (4) mitochondrial function, and (5) cell adhesion/communication and others (pseudogenes, non-coding RNA, miscellaneous genes, and uncharacterized genes). We conclude that VEGF plays a key role in CR by altering the expression of genes that regulate proliferation, immune response, energy metabolism and cell structure, and biological processes that are essential to development and likely CR. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Neurosteroid involvement in threatened preterm labour.
- Author
-
Turkmen, Sahruh, Bäckström, Torbjörn, Kangas Flodin, Yvonne, and Bixo, Marie
- Subjects
PREMATURE labor ,PREGNANOLONE ,OXYTOCIN - Abstract
Introduction: The neurosteroid allopregnanolone modulates oxytocin expression in the brain, and its effects arise from its action on the GABAA receptor. Whether neurosteroid levels and the function of the GABAA receptor are involved in the risk of preterm labour in pregnant women is unknown. Methods: Pregnant women with (n = 16) or without (n = 20) threatened preterm labour (TPL) in gestational week 33 + 6 days to 37 + 0 days were studied prospectively with procedures including foetal heart rate monitoring, vaginal examination, ultrasound examination and blood tests to determine allopregnanolone, progesterone and oxytocin levels. The GABAA receptor function in both groups was measured with a saccadic eye velocity test (SEVT). Results: Plasma oxytocin levels were higher in the TPL group than in the control group (41.5 vs. 37.0 pmol/L, respectively, p =.021). Although the allopregnanolone and progesterone levels in both groups did not differ, there was a negative association between blood oxytocin and allopregnanolone (as predictor) levels in the TPL group (B: −3.2, 95% confidence interval (CI): −5.5 to −0.9, p =.012). As a predictor of TPL, progesterone was associated with cervix maturity (odds ratio: 1.02, 95% CI: 1.00–1.04, p =.038). SEVT showed that the women in both groups had similar GABAA receptor functions. In both groups, body mass index correlated with peak saccadic eye velocity (r =.34, p =.044) and negatively with allopregnanolone (r = −.41, p =.013). Conclusions: Neurosteroid levels were unchanged in the peripheral blood of women with TPL, despite the increase in available oxytocin. Although the function of the GABAA receptor was unchanged in women with TPL, to ensure reliable results, saccadic eye velocity should be investigated during a challenge test with a GABAA receptor agonist. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004–2020 period: a systematic review.
- Author
-
Navajas, Rosana, Corrales, Fernando, and Paradela, Alberto
- Subjects
AMNIOTIC liquid ,PREECLAMPSIA ,BLOOD proteins ,CEREBROSPINAL fluid ,QUANTITATIVE research - Abstract
Background: Quantitative proteomics is an invaluable tool in biomedicine for the massive comparative analysis of protein component of complex biological samples. In the last two decades, this technique has been used to describe proteins potentially involved in the pathophysiological mechanisms of preeclampsia as well as to identify protein biomarkers that could be used with diagnostic/prognostic purposes in pre-eclampsia. Results: We have done a systematic review of all proteomics-based papers describing differentially expressed proteins in this disease. Searching Pubmed with the terms pre-eclampsia and proteomics, restricted to the Title/Abstract and to MeSH fields, and following manual curation of the original list, retrieved 69 original articles corresponding to the 2004–2020 period. We have only considered those results based on quantitative, unbiased proteomics studies conducted in a controlled manner on a cohort of control and pre-eclamptic individuals. The sources of biological material used were serum/plasma (n = 32), placenta (n = 23), urine (n = 9), cerebrospinal fluid (n = 2), amniotic fluid (n = 2) and decidual tissue (n = 1). Overall results were filtered based on two complementary criteria. First, we have only accounted all those proteins described in at least two (urine), three (placenta) and four (serum/plasma) independent studies. Secondly, we considered the consistency of the quantitative data, that is, inter-study agreement in the protein abundance control/pre-eclamptic ratio. The total number of differential proteins in serum/plasma (n = 559), placenta (n = 912), urine (n = 132) and other sources of biological material (n = 26), reached 1631 proteins. Data were highly complementary among studies, resulting from differences on biological sources, sampling strategies, patient stratification, quantitative proteomic analysis methods and statistical data analysis. Therefore, stringent filtering was applied to end up with a cluster of 18, 29 and 16 proteins consistently regulated in pre-eclampsia in placenta, serum/plasma and urine, respectively. The systematic collection, standardization and evaluation of the results, using diverse filtering criteria, provided a panel of 63 proteins whose levels are consistently modified in the context of pre-eclampsia. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease.
- Author
-
Filipe Gouveia, Inês, Raquel Silva, Joana, Santos, Clara, and Carvalho, Claudina
- Published
- 2021
- Full Text
- View/download PDF
43. ISUOG Practice Guidelines: role of ultrasound in congenital infection.
- Author
-
Khalil, A., Sotiriadis, A., Chaoui, R., da Silva Costa, F., D'Antonio, F., Heath, P.T., Jones, C., Malinger, G., Odibo, A., Prefumo, F., Salomon, L. J., Wood, S., and Ville, Y.
- Subjects
RUBELLA ,FETAL diseases ,NEONATAL infections ,HEARING disorders ,MEDICAL personnel ,INFECTION - Abstract
Despite the fact that case reports of intrauterine herpes simplex virus (HSV) infection have been published, this infection is not included herein, as the majority of neonatal HSV infections are acquired at birth as a consequence of direct fetal contact with the infected birth canal or through an ascending infection after premature rupture of the amniotic membranes. CMV infection may be acquired for the first time during pregnancy (primary infection) or it may result from reactivation of prior infection or reinfection with a different strain of the virus (non-primary infection). Nevertheless, a retrospective study of women with maternal primary infection in the index pregnancy found that, once the diagnosis of fetal infection had been made by PCR confirmation of CMV in the amniotic fluid, ultrasound was found to be more sensitive for the detection of subtle abnormalities associated with the fetal infection[18]. In common with other viral infections, however, the risk of an infected fetus being affected (i.e. risk of developing congenital defects) is greatest when infection occurs earlier in gestation: it is 97% when infection is before 12 weeks and 20% when it is from 12 to 16 weeks, while infection from 16 to 20 weeks is associated with a minimal risk of deafness only[[123], [142], [144]]. Diagnosis of fetal rubella infection Recommendations When primary infection occurs before 12 weeks' gestation, given the risk of fetal infection and the risk of an infected fetus developing severe abnormalities, termination of pregnancy can be considered, even without invasive testing ( B GOOD PRACTICE POINT b ). [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
44. Changes in pregnancy-related serum biomarkers early in gestation are associated with later development of preeclampsia.
- Author
-
Hao, Shiying, You, Jin, Chen, Lin, Zhao, Hui, Huang, Yujuan, Zheng, Le, Tian, Lu, Maric, Ivana, Liu, Xin, Li, Tian, Bianco, Ylayaly K., Winn, Virginia D., Aghaeepour, Nima, Gaudilliere, Brice, Angst, Martin S., Zhou, Xin, Li, Yu-Ming, Mo, Lihong, Wong, Ronald J., and Shaw, Gary M.
- Subjects
PREECLAMPSIA ,PREGNANCY proteins ,PLACENTAL growth factor ,BLOOD proteins ,PREGNANCY ,PROTEIN-tyrosine kinases - Abstract
Background: Placental protein expression plays a crucial role during pregnancy. We hypothesized that: (1) circulating levels of pregnancy-associated, placenta-related proteins throughout gestation reflect the temporal progression of the uncomplicated, full-term pregnancy, and can effectively estimate gestational ages (GAs); and (2) preeclampsia (PE) is associated with disruptions in these protein levels early in gestation; and can identify impending PE. We also compared gestational profiles of proteins in the human and mouse, using pregnant heme oxygenase-1 (HO-1) heterozygote (Het) mice, a mouse model reflecting PE-like symptoms. Methods: Serum levels of placenta-related proteins–leptin (LEP), chorionic somatomammotropin hormone like 1 (CSHL1), elabela (ELA), activin A, soluble fms-like tyrosine kinase 1 (sFlt-1), and placental growth factor (PlGF)–were quantified by ELISA in blood serially collected throughout human pregnancies (20 normal subjects with 66 samples, and 20 subjects who developed PE with 61 samples). Multivariate analysis was performed to estimate the GA in normal pregnancy. Mean-squared errors of GA estimations were used to identify impending PE. The human protein profiles were then compared with those in the pregnant HO-1 Het mice. Results: An elastic net-based gestational dating model was developed (R
2 = 0.76) and validated (R2 = 0.61) using serum levels of the 6 proteins measured at various GAs from women with normal uncomplicated pregnancies. In women who developed PE, the model was not (R2 = -0.17) associated with GA. Deviations from the model estimations were observed in women who developed PE (P = 0.01). The model developed with 5 proteins (ELA excluded) performed similarly from sera from normal human (R2 = 0.68) and WT mouse (R2 = 0.85) pregnancies. Disruptions of this model were observed in both human PE-associated (R2 = 0.27) and mouse HO-1 Het (R2 = 0.30) pregnancies. LEP outperformed sFlt-1 and PlGF in differentiating impending PE at early human and late mouse GAs. Conclusions: Serum placenta-related protein profiles are temporally regulated throughout normal pregnancies and significantly disrupted in women who develop PE. LEP changes earlier than the well-established biomarkers (sFlt-1 and PlGF). There may be evidence of a causative action of HO-1 deficiency in LEP upregulation in a PE-like murine model. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
45. Immunobiology of Cervix Ripening.
- Author
-
Yellon, Steven M.
- Subjects
PREMATURE labor ,IMMUNOLOGY ,CELL nuclei ,PARTURITION ,INFLAMMATION ,ASPHYXIA neonatorum ,PUERPERAL disorders - Abstract
The cervix is the essential gatekeeper for birth. Incomplete cervix remodeling contributes to problems with delivery at or post-term while preterm birth is a major factor in perinatal morbidity and mortality in newborns. Lack of cervix biopsies from women during the period preceding term or preterm birth have led to use of rodent models to advanced understanding of the mechanism for prepartum cervix remodeling. The critical transition from a soft cervix to a compliant prepartum lower uterine segment has only recently been recognized to occur in various mammalian species when progesterone in circulation is at or near the peak of pregnancy in preparation for birth. In rodents, characterization of ripening resembles an inflammatory process with a temporal coincidence of decreased density of cell nuclei, decline in cross-linked extracellular collagen, and increased presence of macrophages in the cervix. Although a role for inflammation in parturition and cervix remodeling is not a new concept, a comprehensive examination of literature in this review reveals that many conclusions are drawn from comparisons before and after ripening has occurred, not during the process. The present review focuses on essential phenotypes and functions of resident myeloid and possibly other immune cells to bridge the gap with evidence that specific biomarkers may assess the progress of ripening both at term and with preterm birth. Moreover, use of endpoints to determine the effectiveness of various therapeutic approaches to forestall remodeling and reduce risks for preterm birth, or facilitate ripening to promote parturition will improve the postpartum well-being of mothers and newborns. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
46. Multifactorial Regulation of Myometrial Contractility During Pregnancy and Parturition.
- Author
-
Mendelson, Carole R., Gao, Lu, and Montalbano, Alina P.
- Subjects
PARTURITION ,PREGNANCY ,CONTRACTILE proteins ,GENETIC regulation ,TRANSCRIPTION factors ,NUCLEAR receptors (Biochemistry) ,GENE expression - Abstract
The steroid hormones progesterone (P
4 ) and estradiol-17β (E2 ), produced by the placenta in humans and the ovaries in rodents, serve crucial roles in the maintenance of pregnancy, and the initiation of parturition. Because of their critical importance for species survival, the mechanisms whereby P4 and its nuclear receptor (PR) maintain myometrial quiescence during pregnancy, and for the decline in P4 /PR and increase in E2 /estrogen receptor (ER) function leading to parturition, are multifaceted, cooperative, and redundant. These actions of P4 /PR include: (1) PR interaction with proinflammatory transcription factors, nuclear factor κB (NF-κB), and activating protein 1 (AP-1) bound to promoters of proinflammatory and contractile/contraction-associated protein (CAP) genes and recruitment of corepressors to inhibit NF-κB and AP-1 activation of gene expression; (2) upregulation of inhibitors of proinflammatory transcription factor activation (IκBα, MKP-1); (3) induction of transcriptional repressors of CAP genes (e.g., ZEB1). In rodents and most other mammals, circulating maternal P4 levels remain elevated throughout most of pregnancy and decline precipitously near term. By contrast, in humans, circulating P4 levels and myometrial PR levels remain elevated throughout pregnancy and into labor. However, even in rodents, wherein P4 levels decline near term, P4 levels remain higher than the Kd for PR binding. Thus, parturition is initiated in all species by a series of molecular events that antagonize the P4 /PR maintenance of uterine quiescence. These events include: direct interaction of inflammatory transcription factors (e.g., NF-κB, AP-1) with PR; increased expression of P4 metabolizing enzymes; increased expression of truncated/inhibitory PR isoforms; altered expression of PR coactivators and corepressors. This article will review various mechanisms whereby P4 acting through PR isoforms maintains myometrial quiescence during pregnancy as well as those that underlie the decline in PR function leading to labor. The roles of P4 - and E2 -regulated miRNAs in the regulation and integration of these mechanisms will also be considered. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
47. Uromodulin in mineral metabolism.
- Author
-
Wolf, Matthias T.F., Zhang, Jing, and Nie, Mingzhu
- Published
- 2019
- Full Text
- View/download PDF
48. A gyulladásos és immunológiai folyamatok kapcsolata a várandósság alatt. Gyakorlati vonatkozások.
- Author
-
Fülöp, Vilmos, Vermes, Gábor, and Demeter, János
- Abstract
Copyright of Hungarian Medical Journal / Orvosi Hetilap is the property of Akademiai Kiado and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2019
- Full Text
- View/download PDF
49. Isobaric tag for relative and absolute quantitation based quantitative proteomics reveals unique urinary protein profiles in patients with preeclampsia.
- Author
-
Ding, Wenyan, Qiu, Bintao, Cram, David S., Chen, Xiuting, Li, Shengjie, Zhou, Xiya, Liu, Juntao, Wu, Zhihong, and Song, Yijun
- Subjects
PREECLAMPSIA ,PROTEOMICS ,CELL adhesion molecules ,RENIN-angiotensin system ,PREGNANT women ,PROTEINS - Abstract
Preeclampsia (PE) is one of the most significant pregnancy‐related hypertensive disorders. Currently, there are no useful markers to predict the onset of the condition in pregnant women. To provide further insights into the pathogenesis of PE and identify biomarkers of the condition, we used isobaric tags for relative and absolute quantitation (iTRAQ) proteomics coupled with 2‐D LC‐MS/MS, to analyze urinary protein profiles from 7 PE patients and 7 normotensive pregnant women. A total of 294 proteins were abnormally expressed in PE patients. Of these, 233 were significantly down‐regulated and 61 proteins were significantly up‐regulated. Bioinformatics analysis using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) database, found that the most differentially expressed proteins (DEPs) were involved in coagulation and complement pathways, the renin‐angiotensin system and cell adhesion molecules (CAMs) pathways. We further validated three of the DEPs, including serotransferrin (TF) and complement factor B (CFB) by immunoblottingand serum paraoxonase/arylesterase 1 (PON1) by ELISA using 14 pairs of urine samples from PE patients and normal pregnant women. Taken together, our results provide the basis for further understanding the pathogenesis of PE and identifying predictive biomarkers. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
50. Proteomic investigations into hypertension: what's new and how might it affect clinical practice?
- Author
-
Corbacho-Alonso, N., Rodríguez-Sánchez, E., Martin-Rojas, T., Mouriño-Alvarez, L., Sastre-Oliva, T., Hernandez-Fernandez, G., Padial, L. R., Ruilope, L. M., Ruiz-Hurtado, G., and Barderas, M. G.
- Abstract
Introduction: Hypertension is a multifactorial disease that has, thus far, proven to be a difficult target for pharmacological intervention. The application of proteomic strategies may help to identify new biomarkers for the early diagnosis and prompt treatment of hypertension, in order to control blood pressure and prevent organ damage. Areas covered: Advances in proteomics have led to the discovery of new biomarkers to help track the pathophysiological processes implicated in hypertension. These findings not only help to better understand the nature of the disease, but will also contribute to the clinical needs for a timely diagnosis and more precise treatment. In this review, we provide an overview of new biomarkers identified in hypertension through the application of proteomic techniques, and we also discuss the difficulties and challenges in identifying biomarkers in this clinical setting. We performed a literature search in PubMed with the key words 'hypertension' and 'proteomics', and focused specifically on the most recent literature on the utility of proteomics in hypertension research. Expert opinion: There have been several promising biomarkers of hypertension identified by proteomics, but too few have been introduced to the clinic. Thus, further investigations in larger cohorts are necessary to test the feasibility of this strategy for patients. Also, this emerging field would profit from more collaboration between clinicians and researchers. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.